697305-48-9

Basic information

• Product Name: 1-(4-Fluorophenyl)piperazin-2-one hydrochloride
• Synonyms: 1-(4-Fluorophenyl)piperazin-2-one hydrochloride
• CAS NO: 697305-48-9
• Molecular Formula: C₁₀H₁₁FN₂O*ClH
• Molecular Weight: 230.6664832
• Mol File: 697305-48-9.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 1-(4-Fluorophenyl)piperazin-2-one hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-Fluorophenyl)piperazin-2-one hydrochloride(697305-48-9)
• EPA Substance Registry System: 1-(4-Fluorophenyl)piperazin-2-one hydrochloride(697305-48-9)

Safety Data

• Hazardous Substances Data: 697305-48-9(Hazardous Substances Data)

Usage

Uses

1-(4-Fluorophenyl)piperazin-2-one hydrochloride is used in the preperation of selective somatostatin receptor 2 agonists for treatment of type 2 diabetes

Upstream product

• 1284243-44-2 tert-butyl 4-(4-fluorophenyl)-3-oxopiperazine-1-carboxylate 
• 460-00-4 1-Bromo-4-fluorobenzene 
• 371-40-4 4-fluoroaniline 
• 351-04-2 2-chloro-N-(4-fluorophenyl)acetamide 
• 329079-68-7 N-(4-fluorophenyl)-2-[(2-hydroxyethyl)amino]acetamide 

Downstream Products

• 697308-64-8 N-[(1R,2S)-1-({[5-[(dimethylamino)methyl]-2-ethoxyphenyl]amino}carbonyl)-2-(1H-indol-3-yl)propyl]-4-(4-fluorophenyl)-3-oxopiperazine-1-carboxamide 
• 697304-76-0 ethyl (2R,3S)-2-({[4-(4-fluorophenyl)-3-oxopiperazin-1-yl]carbonyl}amino)-3-(1H-indol-3-yl)butanoate 
• 1284243-40-8 4-{[3-chloro-6-(3-furanyl)-8-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]carbonyl}-1-(4-fluorophenyl)-2-piperazinone 
• 1284243-45-3 4-{[3-chloro-6-(1H-pyrazol-4-yl)-8-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]carbonyl}-1-(4-fluorophenyl)-2-piperazinone 

Relevant articles and documents

Design and synthesis of a novel series of orally active, selective somatostatin receptor 2 agonists for the treatment of type 2 diabetes

The discovery of a novel series of β-methyltryptophan (β MeTrp) derivatives as selective and orally active non-peptide somatostatin receptor 2 (SSTR2) agonists for the treatment of Type 2 diabetes is described. In our previous research, Compound A, β-MeTr

PIPERAZINYL ANTIVIRAL AGENTS

Provided are compounds of Formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).